Exclusive

Publication

Byline

Location

Lyra Therapeutics Stock Soars 480% On Positive Trial Results Of LYR-210

India, June 2 -- Shares of Lyra Therapeutics, Inc. (LYRA) soared 480% on Monday morning after the clinical-stage biotechnology company announced positive results from the phase 3 trial of LYR-210, whi... Read More


Sensex, Nifty Tumble As Trade Worries Return To Haunt

India, June 2 -- Indian shares opened on a sluggish note Monday, with concerns over global trade and tariffs keeping investors on edge. U.S. President Donald Trump accused China of violating their ag... Read More


Energy, Materials Stocks Shine As TSX Rises 0.5%

India, June 2 -- The Canadian market is up in positive territory a little past noon on Monday, lifted by gains in energy, materials and communications sectors, even as the mood remains cautious amid c... Read More


HCM : Phase III Study Of Savolitinib Combo Shows Promising Results For EGFR-Mutated NSCLC Treatment

India, June 1 -- HUTCHMED (China) Limited (HCM) announced that results from the SACHI Phase III study represent a significant advancement in the treatment of EGFR mutation-positive NSCLC with MET ampl... Read More


AstraZeneca Says Camizestrant Reduces Risk Of Disease Progression By 56% In SERENA-6 Phase III Trial

India, June 1 -- AstraZeneca PLC (AZN) announced positive results from the SERENA-6 Phase III trial, demonstrating that camizestrant, in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor,... Read More


Rio Tinto And PKKP Aboriginal Corporation Sign Agreement To Protect Heritage

India, June 1 -- The Puutu Kunti Kurrama and Pinikura (PKKP) Aboriginal Corporation and Rio Tinto have agreed to work together to build a strong and lasting partnership. This agreement sets clear rul... Read More


Nxera Pharma Reaches Key Milestone In Lilly Partnership For Diabetes & Metabolic Disease Research

India, June 1 -- Nxera Pharma Co., Ltd. announced that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Co. (LLY) targeting diabete... Read More


FDA Reviews Kura's NDA For Ziftomenib To Treat Acute Myeloid Leukemia With NPM1 Mutation

India, June 1 -- Kura Oncology Inc. (KURA) and Kyowa Kirin Co., Ltd. announced the U.S. Food and Drug Administration has accepted Kuras New Drug Application or NDA seeking full approval for ziftomenib... Read More


Japan Manufacturing PMI Shows Slight Improvement - Jibun

India, June 1 -- The manufacturing sector in Japan continued to contract in May, albeit at a slower pace, the latest survey from Jibun Bank revealed on Monday with a manufacturing PMI score of 49.4. ... Read More


South Korea Manufacturing PMI Climbs To 47.7 - S&P Global

India, June 1 -- The manufacturing sector in South Korea continued to contract in May, albeit at a slower pace, the latest survey from S&P Global revealed on Monday with a manufacturing PMI score of 4... Read More